PL3525799T3 - Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka - Google Patents

Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka

Info

Publication number
PL3525799T3
PL3525799T3 PL17817868T PL17817868T PL3525799T3 PL 3525799 T3 PL3525799 T3 PL 3525799T3 PL 17817868 T PL17817868 T PL 17817868T PL 17817868 T PL17817868 T PL 17817868T PL 3525799 T3 PL3525799 T3 PL 3525799T3
Authority
PL
Poland
Prior art keywords
restoring
establishing
ocular surface
homeostasis
preserving
Prior art date
Application number
PL17817868T
Other languages
English (en)
Polish (pl)
Inventor
Wolfgang Georg Konrad Muller-Lierheim
Gysbert-Botho Van Setten
Original Assignee
i.com medical GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60766004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3525799(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by i.com medical GmbH filed Critical i.com medical GmbH
Publication of PL3525799T3 publication Critical patent/PL3525799T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL17817868T 2016-10-14 2017-10-02 Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka PL3525799T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662408559P 2016-10-14 2016-10-14
US201762516911P 2017-06-08 2017-06-08
EP17817868.7A EP3525799B1 (en) 2016-10-14 2017-10-02 Method for establishing, restoring, and preserving homeostasis of the ocular surface
PCT/IB2017/001364 WO2018069763A1 (en) 2016-10-14 2017-10-02 Method for establishing, restoring, and preserving homeostasis of the ocular surface

Publications (1)

Publication Number Publication Date
PL3525799T3 true PL3525799T3 (pl) 2022-05-16

Family

ID=60766004

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17817868T PL3525799T3 (pl) 2016-10-14 2017-10-02 Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka

Country Status (8)

Country Link
US (1) US20190240251A1 (https=)
EP (2) EP3871682A1 (https=)
JP (3) JP2019532105A (https=)
KR (1) KR20190068575A (https=)
ES (1) ES2909998T3 (https=)
HU (1) HUE058672T2 (https=)
PL (1) PL3525799T3 (https=)
WO (1) WO2018069763A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190240251A1 (en) 2016-10-14 2019-08-08 i.com medical GmbH Method for establishing, restoring, and preserving homeostasis of the ocular surface
CN112292135A (zh) 2018-04-18 2021-01-29 I.Com医疗有限责任公司 用于治疗和预防严重眼表疾病的高分子量透明质酸
CN112714644B (zh) * 2018-09-20 2024-03-29 香港科技大学 滴眼剂组合物
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
EP4106772A1 (en) * 2020-06-12 2022-12-28 i.com Medical GmbH High molecular weight hyaluronic acid for use in the treatment of corneal nerve damage or loss
PL4167965T3 (pl) * 2020-06-21 2025-03-24 i.com medical GmbH Zastosowanie kwasu hialuronowego o wysokiej masie cząsteczkowej jako nośnika do transportu do oczu
MX2024015185A (es) * 2022-06-08 2025-06-02 Schepens Eye Res Inst Metodos para tratar la enfermedad del ojo seco
EP4591860A1 (en) * 2024-01-23 2025-07-30 FB Vision S.p.A. Ophthalmic pharmaceutical composition for the prevention and treatment of dry eye syndrome

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
JP3050898B2 (ja) * 1990-07-06 2000-06-12 千寿製薬株式会社 水性医薬製剤
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
IT1277707B1 (it) * 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
SE9700827D0 (sv) * 1997-03-07 1997-03-07 Pharmacia & Upjohn Ab Ophthalmic composition
EP1142566B1 (fr) * 2000-04-07 2003-10-01 Laboratoire Medidom S.A. Formulations ophtalmiques à base de ciclosporine, d'acide hyaluronique et du polysorbate
US6528464B1 (en) * 2001-08-17 2003-03-04 Bausch & Lomb Incorporated Composition and method for inhibiting uptake of biguanide antimicrobials by hydrogels
JP3779200B2 (ja) * 2001-11-28 2006-05-24 電気化学工業株式会社 ヒアルロン酸及び／又はその塩の水溶液の安定化組成物
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
MXPA05000186A (es) * 2002-07-03 2005-08-17 Pericor Science Inc Composiciones de acido hialuronico y metodos de uso.
DE10360425A1 (de) 2003-12-19 2005-07-28 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung
CA2625532C (en) * 2005-10-12 2013-10-01 Seikagaku Corporation Agent for applying to mucosa containing a hydrophobic group binding type glycosaminoglycan
JP2008255061A (ja) * 2007-04-06 2008-10-23 Shiseido Co Ltd 可溶性架橋ヒアルロン酸含有眼用組成物
US10105441B2 (en) * 2007-08-16 2018-10-23 The Schepens Eye Research Institute, Inc. Method for inhibiting or reducing dry eye disease by IL-1Ra
CN102026648A (zh) * 2008-05-15 2011-04-20 株式会社·R-技术上野 用于治疗干眼和/或角膜结膜损伤的药物组合物
JP5595206B2 (ja) * 2009-09-30 2014-09-24 ロート製薬株式会社 眼科用液体組成物
US8283463B2 (en) * 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
CN103221422B (zh) * 2010-07-29 2017-03-29 十一生物治疗股份有限公司 嵌合il‑1受体i型激动剂和拮抗剂
PL2614838T3 (pl) * 2010-09-10 2016-10-31 Dikwafozol i kwas hialuronowy lub ich sole do zastosowania w leczeniu zespołu suchego oka
JP6692808B2 (ja) * 2014-12-02 2020-05-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ドライアイ用動物モデルおよびこうした動物の使用方法
JP6716293B2 (ja) * 2015-03-06 2020-07-01 参天製薬株式会社 眼科用組成物
US20170014339A1 (en) 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
US20190240251A1 (en) 2016-10-14 2019-08-08 i.com medical GmbH Method for establishing, restoring, and preserving homeostasis of the ocular surface
CN112292135A (zh) * 2018-04-18 2021-01-29 I.Com医疗有限责任公司 用于治疗和预防严重眼表疾病的高分子量透明质酸
US12268706B2 (en) * 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain

Also Published As

Publication number Publication date
ES2909998T3 (es) 2022-05-11
US20190240251A1 (en) 2019-08-08
JP2025029084A (ja) 2025-03-05
EP3525799B1 (en) 2022-01-26
EP3525799A1 (en) 2019-08-21
WO2018069763A1 (en) 2018-04-19
HUE058672T2 (hu) 2022-09-28
JP2022153583A (ja) 2022-10-12
KR20190068575A (ko) 2019-06-18
EP3871682A1 (en) 2021-09-01
JP2019532105A (ja) 2019-11-07

Similar Documents

Publication Publication Date Title
IL266596A (en) Causes, uses and methods of treating synovialitis
PL3525799T3 (pl) Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka
IL254533A0 (en) Systems and methods for heart valve therapy
IL256501B (en) Causes, uses and methods of treating synuclein pathology
IL269490B (en) Surface treatment methods and compositions therefor
EP3151797A4 (en) Methods and devices for treating the skin
PL3648595T3 (pl) Sposób konserwacji pyłku
SG11201801790UA (en) Polishing liquid, polishing liquid set, and substrate polishing method
EP3252124A4 (en) Surface treatment agent
EP3119532A4 (en) Treated article and method of making the same
SG10202003053VA (en) Deactivation wipe kit and method of forming and using the same
SG11202001013YA (en) Polishing liquid, polishing liquid set and polishing method
EP3484515A4 (en) METHOD FOR TREATING FIBROSE
IL271728A (en) Materials, uses and treatment methods
EP3375568A4 (en) Surface treatment device and surface treatment method
PT3430883T (pt) Aparelho de varejar, particularmente para varejar oliveiras e semelhantes
SG11202002314WA (en) Polishing solution, polishing solution set, and polishing method
EP3551027B8 (en) Machine for the drying of dishes or the like and method for the drying of dishes or the like with said machine.
EP3219787A4 (en) Agent for preserving biological component, and method for recovering biological component
EP3176149A4 (en) Method for improving preservation stability of 2,2-difluoroacetoaldehyde
TWI561676B (en) Aqueous metal surface treatment agent and metal surface treatment method using the same
EP3423063A4 (en) COMPOSITIONS AND METHODS FOR TREATING SEARCH OR SUBSTANCE ABUSE MISTAKES
PT3585985T (pt) Método de conservação
EP3458624A4 (en) SURFACE TREATMENT METHOD
HK40028708A (en) Agents, uses and methods for treatment